Takura has acquired all shares in clinical stage immuno-oncology company Polybiocept GmbH (PBC). Takura was already a minority owner in the company which owns a patent portfolio for TIL (tumor infiltrating lymphocytes) therapy. Immunotherapy is one of the fastest growing segments in the pharmaceutical industry and has the potential to revolutionize cancer care. PBC has […]
Om Maria Rankka
Författaren har inte skrivit något ännu.Meanwhile lets just say that we are proud Maria Rankka contributed a whooping 1 entries.
Inlägg av Maria Rankka
Takura is a Swedish company that commercializes advanced cell therapy research in order to accelerate the development and make groundbreaking treatments accessible and more affordable.